Zylox-Tonbridge Medical Repurchases 59,000 H Shares, Lifts Treasury Stock to 12.51 Million

Bulletin Express

Jul 08

Zylox-Tonbridge Medical Technology Co., Ltd. executed an on-market repurchase of 59,000 H shares on 8 July 2026.

• Pricing and consideration: The shares were bought back on the Hong Kong Stock Exchange at prices between HKD 19.04 and HKD 19.43, for a total consideration of HKD 1.13 million (volume-weighted average price: HKD 19.22).

• Impact on share capital: – Issued shares excluding treasury stock fell 0.0178 % to 323.84 million. – Treasury shares increased to 12.51 million. – Total issued shares remained unchanged at 336.35 million.

• Mandate utilisation: The repurchase was made under the mandate approved on 13 May 2026, which allows up to 32.72 million shares to be bought back. Cumulative purchases under this authority now total 3.36 million shares, representing 1.00 % of the company’s issued shares on the mandate date.

• Post-repurchase restrictions: In line with Hong Kong listing rules, Zylox-Tonbridge may not issue new shares or dispose of treasury shares until 7 August 2026.

The board confirmed that the transaction complied with all applicable listing rules and regulatory requirements, and all related funds have been fully settled.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1190516893"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1190516893\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1190516893?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-08 19:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1190516893","market":"us","top_or_hot":-1,"title":"Zylox-Tonbridge Medical Repurchases 59,000 H Shares, Lifts Treasury Stock to 12.51 Million","media":"Bulletin Express","content":"<p>Zylox-Tonbridge Medical Technology Co., Ltd. executed an on-market repurchase of 59,000 H shares on 8 July 2026.</p>\n<p>• Pricing and consideration: The shares were bought back on the Hong Kong Stock Exchange at prices between HKD 19.04 and HKD 19.43, for a total consideration of HKD 1.13 million (volume-weighted average price: HKD 19.22).</p>\n<p>• Impact on share capital:  \n  – Issued shares excluding treasury stock fell 0.0178 % to 323.84 million.  \n  – Treasury shares increased to 12.51 million.  \n  – Total issued shares remained unchanged at 336.35 million.</p>\n<p>• Mandate utilisation: The repurchase was made under the mandate approved on 13 May 2026, which allows up to 32.72 million shares to be bought back. Cumulative purchases under this authority now total 3.36 million shares, representing 1.00 % of the company’s issued shares on the mandate date.</p>\n<p>• Post-repurchase restrictions: In line with Hong Kong listing rules, Zylox-Tonbridge may not issue new shares or dispose of treasury shares until 7 August 2026.</p>\n<p>The board confirmed that the transaction complied with all applicable listing rules and regulatory requirements, and all related funds have been fully settled.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Zylox-Tonbridge Medical Repurchases 59,000 H Shares, Lifts Treasury Stock to 12.51 Million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nZylox-Tonbridge Medical Repurchases 59,000 H Shares, Lifts Treasury Stock to 12.51 Million\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-07-08 19:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Zylox-Tonbridge Medical Technology Co., Ltd. executed an on-market repurchase of 59,000 H shares on 8 July 2026.</p>\n<p>• Pricing and consideration: The shares were bought back on the Hong Kong Stock Exchange at prices between HKD 19.04 and HKD 19.43, for a total consideration of HKD 1.13 million (volume-weighted average price: HKD 19.22).</p>\n<p>• Impact on share capital:  \n  – Issued shares excluding treasury stock fell 0.0178 % to 323.84 million.  \n  – Treasury shares increased to 12.51 million.  \n  – Total issued shares remained unchanged at 336.35 million.</p>\n<p>• Mandate utilisation: The repurchase was made under the mandate approved on 13 May 2026, which allows up to 32.72 million shares to be bought back. Cumulative purchases under this authority now total 3.36 million shares, representing 1.00 % of the company’s issued shares on the mandate date.</p>\n<p>• Post-repurchase restrictions: In line with Hong Kong listing rules, Zylox-Tonbridge may not issue new shares or dispose of treasury shares until 7 August 2026.</p>\n<p>The board confirmed that the transaction complied with all applicable listing rules and regulatory requirements, and all related funds have been fully settled.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02190","symbol_name":"归创通桥","start_time":0,"source_url":"","article_id":"1190516893","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1190516893","pubTimestamp":1783508676,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Zylox-Tonbridge Medical Technology Co., Ltd. executed an on-market repurchase of 59,000 H shares on 8 July 2026. • Pricing and consideration: The shares were bought back on the Hong Kong Stock...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02190":"归创通桥"},"translate_title":"归乐通桥医疗回购5.9万股H股库存股增至1251万股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02190":1},"content_text":"Zylox-Tonbridge Medical Technology Co., Ltd. executed an on-market repurchase of 59,000 H shares on 8 July 2026.\n• Pricing and consideration: The shares were bought back on the Hong Kong Stock Exchange at prices between HKD 19.04 and HKD 19.43, for a total consideration of HKD 1.13 million (volume-weighted average price: HKD 19.22).\n• Impact on share capital:  \n  – Issued shares excluding treasury stock fell 0.0178 % to 323.84 million.  \n  – Treasury shares increased to 12.51 million.  \n  – Total issued shares remained unchanged at 336.35 million.\n• Mandate utilisation: The repurchase was made under the mandate approved on 13 May 2026, which allows up to 32.72 million shares to be bought back. Cumulative purchases under this authority now total 3.36 million shares, representing 1.00 % of the company’s issued shares on the mandate date.\n• Post-repurchase restrictions: In line with Hong Kong listing rules, Zylox-Tonbridge may not issue new shares or dispose of treasury shares until 7 August 2026.\nThe board confirmed that the transaction complied with all applicable listing rules and regulatory requirements, and all related funds have been fully settled.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}